A. D2 dopamine receptor activation on lactotrophs reduces cAMP signaling and prolactin release
Why this is correct
Dopamine from hypothalamic tuberoinfundibular neurons tonically inhibits anterior pituitary lactotrophs through D2 receptors, which are Gi-coupled. Cabergoline is a long-acting D2 receptor agonist that suppresses prolactin secretion and often shrinks prolactinomas. Excess prolactin inhibits hypothalamic pulsatile GnRH, lowering gonadotropins and producing menstrual irregularity, anovulation and infertility. Evaluation should exclude physiologic, medication and endocrine causes of hyperprolactinemia.
Why each option is correct or incorrect
Correct: stimulation of Gi-coupled D2 receptors suppresses prolactin release and tumor secretory activity.
V1 vasopressin receptors are not the main regulatory brake on lactotroph prolactin secretion.
Estrogen generally can stimulate prolactin synthesis rather than lower it.
GH receptor blockade targets growth hormone action and does not directly provide dopamine's inhibitory effect on lactotrophs.
High-yield notes
- Dopamine tonically inhibits prolactin secretion.
- D2 receptors are Gi-coupled; cabergoline is a D2 agonist.
- Hyperprolactinemia suppresses GnRH, causing hypogonadotropic reproductive dysfunction.
Cabergoline treats prolactinoma by mimicking dopamine's physiologic inhibitory signal.
Do not confuse dopamine agonists with dopamine antagonists such as antipsychotics, which often raise prolactin.